MERRIMACK PHARMACEUTICALS IN's ticker is and the CUSIP is 590328AA8. A total of 15 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q1 2015. The put-call ratio across all filers is - and the average weighting 1.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $2,838,000 | -41.8% | 3,300,000 | -47.6% | 0.01% | -44.4% |
| Q2 2017 | $4,874,000 | -8.2% | 6,300,000 | 0.0% | 0.01% | -10.0% |
| Q1 2017 | $5,311,000 | -9.8% | 6,300,000 | 0.0% | 0.01% | -16.7% |
| Q4 2016 | $5,890,000 | -61.6% | 6,300,000 | -49.5% | 0.01% | -60.0% |
| Q3 2016 | $15,349,000 | -14.1% | 12,469,000 | -21.9% | 0.03% | -21.1% |
| Q2 2016 | $17,865,000 | -24.9% | 15,969,000 | 0.0% | 0.04% | -26.9% |
| Q1 2016 | $23,793,000 | +0.3% | 15,969,000 | 0.0% | 0.05% | -3.7% |
| Q4 2015 | $23,723,000 | +36.5% | 15,969,000 | +45.0% | 0.05% | +28.6% |
| Q3 2015 | $17,375,000 | -8.0% | 11,010,000 | +22.2% | 0.04% | +5.0% |
| Q2 2015 | $18,887,000 | +172.8% | 9,010,000 | +156.7% | 0.04% | +166.7% |
| Q1 2015 | $6,923,000 | +3.4% | 3,510,000 | 0.0% | 0.02% | +7.1% |
| Q4 2014 | $6,693,000 | -3.4% | 3,510,000 | -21.3% | 0.01% | -6.7% |
| Q3 2014 | $6,932,000 | -14.9% | 4,460,000 | -27.5% | 0.02% | -11.8% |
| Q2 2014 | $8,141,000 | -26.5% | 6,150,000 | -43.8% | 0.02% | -32.0% |
| Q1 2014 | $11,073,000 | +26.9% | 10,950,000 | +29.5% | 0.02% | +31.6% |
| Q4 2013 | $8,729,000 | +92.9% | 8,455,000 | +69.1% | 0.02% | +72.7% |
| Q3 2013 | $4,525,000 | – | 5,000,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|